Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuiwang Qing

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Management and Research|November 15, 2018
Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancerXiaofei Zhu, Fuqi Li, Dongchen Shi, et al.
Frontiers in Oncology|November 19, 2021
Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive CasesYuxin Shen, Xiaofei Zhu, Fei Cao, et al.
Cancer Biology & Medicine|June 27, 2020
Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modificationsXiaofei Zhu, Di Chen, Yangsen Cao, et al.
Cancer Medicine|May 18, 2018
Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancerXiaofei Zhu, Dongchen Shi, Fuqi Li, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort studyXiaofei Zhu, Yangsen Cao, Tingshi Su, et al.
Cancer Management and Research|June 7, 2018
Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected databaseXiaofei Zhu, Fuqi Li, Wenyu Liu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Management and Research|November 15, 2018
Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancerXiaofei Zhu, Fuqi Li, Dongchen Shi, et al.
Frontiers in Oncology|November 19, 2021
Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive CasesYuxin Shen, Xiaofei Zhu, Fei Cao, et al.
Cancer Biology & Medicine|June 27, 2020
Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modificationsXiaofei Zhu, Di Chen, Yangsen Cao, et al.
Cancer Medicine|May 18, 2018
Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancerXiaofei Zhu, Dongchen Shi, Fuqi Li, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort studyXiaofei Zhu, Yangsen Cao, Tingshi Su, et al.
Cancer Management and Research|June 7, 2018
Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected databaseXiaofei Zhu, Fuqi Li, Wenyu Liu, et al.
Pageof 2